Inventor · disambiguated record
Thomas Macallister
Also filed as: MACALLISTER THOMAS · MACALLISTER THOMAS W
21 granted patents·36 pending applications·52 citations·filing 1992–2025
93Inventor score
Files withWOOLSEY PHARMACEUTICALS INC31REMEDY PHARMACEUTICALS INC9MARTIN PHARMACEUTICALS INC6BIOGEN CHESAPEAKE LLC3ME MEDICAL ENZYMES AG3
Top patents by PatentIndex Score
57 records- 0197US12251389B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Granted Mar 18, 2025·6 cites·30 claims
- 0295US12251388B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2024·Granted Mar 18, 2025·4 cites·14 claims
- 0395US11311553B1Methods of treating 4-repeat tauopathiesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Apr 26, 2022·5 cites·18 claims
- 0494US11771704B1Methods of using rho kinase inhibitors to treat alzheimer's diseaseWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Oct 3, 2023·1 cites·13 claims
- 0594US11642352B2Methods of treating wandering in Lewy dody dementiaWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted May 9, 2023·3 cites·12 claims
- 0691US11865119B2Methods of treating agitation and other dementia-associated behavioral symptomsWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Jan 9, 2024·1 cites·27 claims
- 0789US11944633B2Oral formulations of fasudil with ion exchange resinWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Apr 2, 2024·1 cites·25 claims
- 0887US11666583B2Methods of treating cortical dementia associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Jun 6, 2023·1 cites·15 claims
- 0983US2025032441A1Method of Treating AscitesMARTIN PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 1083US2025345347A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1182US12290522B2Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted May 6, 2025·0 cites·22 claims
- 1281US10946011B2Stable oral liquid formulation of trimetazidineMARTIN PHARMACEUTICALS INC·Filed 2019·Granted Mar 16, 2021·1 cites·17 claims
- 1379US2025339448A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 1479US2024100064A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 1578US12337006B1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Granted Jun 24, 2025·0 cites·30 claims
- 1678US12115167B2Oral formulations of fasudil with ion exchange resinWOOLSEY PHARMACEUTICALS INC·Filed 2024·Granted Oct 15, 2024·0 cites·23 claims
- 1776US12268661B2Methods of treating ascitesMARTIN PHARMACEUTICALS INC·Filed 2021·Granted Apr 8, 2025·0 cites·12 claims
- 1876US11779588B2Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Oct 10, 2023·0 cites·16 claims
- 1975US2025268911A1Methods of Using RHO Kinase Inhibitors to Treat Alzheimer's DiseaseWOOLSEY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2073US12329761B2Methods of using rho kinase inhibitors to treat alzheimer's diseaseWOOLSEY PHARMACEUTICALS INC·Filed 2021·Granted Jun 17, 2025·0 cites·12 claims
- 2173US2025228868A1Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 2272US12274687B2Methods for treating ascitesMARTIN PHARMACEUTICALS INC·Filed 2022·Granted Apr 15, 2025·0 cites·17 claims
- 2372US6939541B2Cloning, overexpression and therapeutic use of bioactive histidine ammonia lyaseUNIV SOUTH CAROLINA·Filed 2001·Granted Sep 6, 2005·5 cites·21 claims
- 2472US2023248739A1Methods of treating cortical dementia associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2572US2023226073A1Methods of treating proteinopathy associated wanderingWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 2671US2021251943A1Method of Treating AscitesJACOBSON SVEN·Filed 2021·Application pending·0 cites
- 2770US7052689B2Method for producing therapeutically suitable glutaminaseME MEDICAL ENZYMES AG·Filed 2001·Granted May 30, 2006·3 cites·6 claims
- 2870US2022047607A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 2970US2022088039A1Methods of medical treatment with sur1-trpm4 channel inhibitorsBIOGEN CHESAPEAKE LLC·Filed 2021·Application pending·0 cites
- 3069US2021145788A1Methods of Treating AscitesMACALLISTER THOMAS W·Filed 2020·Application pending·0 cites
- 3168US2024299410A1Methods of treating familial amyotrophic lateral sclerosis by oral administration of fasudilWOOLSEY PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 3268US2025161330A1Methods of medical treatment with sur1-trpm4 channel inhibitorsREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 3368US2024423998A1Methods of treating agitation and other dementia-associated behavioral symptomsWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 3467US6312939B1Genetically engineered glutaminase and its use in antiviral and anticancer therapyME MEDICAL ENZYMES AG·Filed 1992·Granted Nov 6, 2001·21 cites·17 claims
- 3567US2021401853A1Methods of treating neurodevelopmental disordersWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 3665US2025381197A1Regimen for Treating Amyotrophic Lateral Sclerosis Having Onset 24 Months Prior to TreatmentWOOLSEY PHARMACEUTICALS INC·Filed 2023·Application pending·0 cites
- 3762US2021196707A1Stable Oral Liquid Formulation of TrimetazidineMACALLISTER THOMAS·Filed 2021·Application pending·0 cites
- 3861US12128053B2Taste-masking oral formulations of fasudilWOOLSEY PHARMACEUTICALS INC·Filed 2023·Granted Oct 29, 2024·0 cites·8 claims
- 3961US2024415846A1Method of treating amyotrophic lateral sclerosis and dosing regimen for sameWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4061US2024261298A1Methods of treating depression and anxietyWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4161US2024252511A1Methods of treating depression and anxietyWOOLSEY PHARMACEUTICALS INC·Filed 2022·Application pending·0 cites
- 4260US11304963B2Methods of medical treatment with SUR1-TRPM4 channel inhibitorsBIOGEN CHESAPEAKE LLC·Filed 2017·Granted Apr 19, 2022·0 cites·11 claims
- 4359US2025345346A1Methods of treating ischemic stroke at risk for cerebral or cerebellar edemaREMEDY PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4458US2024423997A1Method of treating amyotrophic lateral sclerosisWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4558US2025144063A1Methods of Treating AscitesMARTIN PHARMACEUTICALS INC·Filed 2025·Application pending·0 cites
- 4654US2023080958A1Methods of treating pseudobulbar affect and other emotional disturbancesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4754US2023263806A1Methods of treating proteinopathiesWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4854US2023285409A1Methods of using rho kinase inhibitors to treat vascular dementiaWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 4954US2023321114A1Methods of treating age-related cognitive declineWOOLSEY PHARMACEUTICALS INC·Filed 2021·Application pending·0 cites
- 5054US2006240414A1Genetically engineered glutaminase and its use in antiviral and anticancer therapyME MEDICAL ENZYMES AG·Filed 2006·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →